Epizyme, Inc.
FLOW CYTOMETRY FOR MONITORING HISTONE H3 METHYLATION STATUS
Last updated:
Abstract:
The present disclosure relates to methods of detecting histone epigenetic modifications and compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
22 Dec 2020
Issue date:
5 Aug 2021